http://www.acsh.org/news/2016/11/29/herpes-vaccines-what-else-out-there-10493
This article has a very encouraging view of admedus vs competing vaccines (see the table). They do mention a Theravax breakthough though, which I found a little confusing. The Start of the article mentions their breakthough but then they aren't in the table.
Race doesn't seem to be over yet and they talk about Admedus as "one to keep your eye on".
Can those across the technical detail please decipher where Theravax sits in relation to the admedus vax?
Herpes Vax comparison
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.15 |
Change
0.350(2.97%) |
Mkt cap ! $256.8M | |||
| Open | High | Low | Value | Volume |
| $11.80 | $12.15 | $11.21 | $376.0K | 32.22K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 139 | $12.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.15 | 830 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |